New Coronary Pneumonia | CDC Investigation of Thrombosis in 2 Women in the United States after Vaccination by Johnson & Johnson

Instant International

Written by: Fang Yimei

2021-04-24 18:32

Last update date: 2021-04-24 18:33

British media quoted a US health official on April 22 that the US Centers for Disease Control and Prevention (CDC) is investigating the occurrence of blood clots after two women were vaccinated with Johnson & Johnson's new coronavirus pneumonia (COVID-19) vaccine. .

One of the women died and the other was admitted to the hospital for treatment.

After many people in the United States experienced thrombotic side effects after being vaccinated with Johnson's single-dose new coronavirus pneumonia vaccine, the authorities recommended on April 13 that the vaccination should be suspended.

The CDC and the Food and Drug Administration (FDA) announced on the 23rd that the suspension of the Johnson & Johnson vaccine injection was lifted.

Today FDA and @CDCgov issued a statement regarding the Johnson & Johnson #COVID19 vaccine. We are recommending a pause in the use of this vaccine out of an abundance of caution.

— US FDA (@US_FDA) April 13, 2021

Johnson & Johnson vaccine: The picture shows a man in New Orleans, USA, receiving the Johnson & Johnson new crown vaccine on March 4.

(AP)

Reuters reported on the 22nd that the health department of Oregon issued a statement stating that a woman in her 50s in the state had been vaccinated before the government recommended a suspension of vaccinations against Johnson & Johnson.

She developed rare and serious blood clots within 2 weeks after vaccination, and had a very low platelet count, and eventually died.

New Crown Vaccine | The United States resumes recommending vaccinations against Johnson & Johnson

New crown pneumonia | US expert group recommends resuming Johnson & Johnson vaccination

New crown pneumonia | Some countries suspend the use of Johnson & Johnson vaccine, European Medicines Agency announces results of review next week

New crown pneumonia | Johnson & Johnson postpones the launch of vaccine in Europe British media: EU seeks explanation

According to the report, a Texas health department spokesperson stated that a woman in the state was admitted to the hospital after being vaccinated by Johnson & Johnson.

As of April 12 in the United States, six women have developed thrombotic symptoms 6 to 13 days after being vaccinated by Johnson & Johnson. The symptoms of this Texas woman are similar to them.

Johnson & Johnson Covid-19 Vaccine Covid-19 U.S.